0001567619-23-005059.txt : 20230314 0001567619-23-005059.hdr.sgml : 20230314 20230314194022 ACCESSION NUMBER: 0001567619-23-005059 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230310 FILED AS OF DATE: 20230314 DATE AS OF CHANGE: 20230314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIENAIME JEAN JACQUES CENTRAL INDEX KEY: 0001221590 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 23732859 MAIL ADDRESS: STREET 1: 925 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2023-03-10 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001221590 BIENAIME JEAN JACQUES C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901 1 1 0 0 Chief Executive Officer Common Stock 2023-03-10 4 M 0 15000 67.81 A 502856 D Common Stock 2023-03-10 4 S 0 15000 92.28 D 487856 D Common Stock 2023-03-13 4 M 0 8000 67.81 A 495856 D Common Stock 2023-03-13 4 S 0 8000 90.45 D 487856 D Common Stock 247333 I Shares held by Jean-Jacques Bienaime Family Trust Common Stock 100 I Shares held as UTMA custodian for child Common Stock 100 I Shares held as UTMA custodian for child Stock Option (Right to buy Common Stock) 67.81 2023-03-10 4 M 0 15000 0 D 2013-11-15 2023-05-14 Common Stock 15000 157130 D Stock Option (Right to buy Common Stock) 67.81 2023-03-13 4 M 0 8000 0 D 2013-11-15 2023-05-14 Common Stock 8000 149130 D Trade made pursuant to a 10b5-1 plan executed on May 3, 2022. Trade made pursuant to a 10b5-1 plan executed on November 17, 2022. Reflects the number of options outstanding after the transactions from this specific stock option grant. /s/ Eric Fleekop, Attorney-in-Fact 2023-03-14